SCHEMBL29324208

SCHEMBL29324208

Cn1nc(C(C)(C)C)c2cc(F)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SSTR4 P31391 4/20 0.51
MEN1 O00255 1/20 0.39
HCRTR1 O43613 1/20 0.39
KMT2A Q03164 1/20 0.39
KDM4E B2RXH2 3/20 0.38
ALDH1A1 P00352 1/20 0.38
KDM4C Q9H3R0 1/20 0.38
GAA P10253 1/20 0.36
NAMPT P43490 3/20 0.36
HSP90AA1 P07900 1/20 0.35
MAPT P10636 2/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
DYRK3 O43781 1/20 0.34
PIM1 P11309 1/20 0.34
MAPK8 P45983 1/20 0.34
MAPK9 P45984 1/20 0.34
MAPK10 P53779 1/20 0.34
DYRK1A Q13627 1/20 0.34
NTRK3 Q16288 1/20 0.34
PIM3 Q86V86 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16252855 0.87 SSTR4 (0.49) SSTR4MEN1HCRTR1KMT2AKDM4E
SCHEMBL15730377 0.86 SSTR4 (0.48) SSTR4MEN1HCRTR1KMT2AKDM4E
SCHEMBL11922101 0.81 HTR1D (0.42) SSTR4MEN1KMT2AALDH1A1GAA
SCHEMBL18538063 0.81 MEN1 (0.37) SSTR4MEN1HCRTR1KMT2AKDM4E
SCHEMBL18538052 0.80 MAPT (0.41) SSTR4MEN1KMT2AKDM4EALDH1A1
SCHEMBL18538041 0.79 MAPK8 (0.45) SSTR4HCRTR1KDM4EKDM4CNAMPT
SCHEMBL18538047 0.79 ADORA2A (0.38) SSTR4
SCHEMBL14077457 0.78 MEN1 (0.42) SSTR4MEN1HCRTR1KMT2AKDM4E
SCHEMBL10221610 0.77 MAPT (0.45) MEN1KMT2AKDM4EALDH1A1GAA
SCHEMBL13106170 0.77 ADORA2A (0.59) SSTR4MEN1HCRTR1KMT2AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240228484-A1 MONOACYLGLYCEROL LIPASE MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2024-07-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240228484-A1 MONOACYLGLYCEROL LIPASE MODULATORS MGLL, LPL, PNLIP SSTR4 1328/4885MEN1 2100/4885HCRTR1 298/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.